Biontech

Latest Stories

A nurse holds a vial of the Pfizer COVID-19 vaccine for children ages 5 to 11, right, and a vial of the vaccine for adults, which has a different colored label, at a vaccination station in Jackson, Miss., Tuesday, Feb. 8, 2022. (AP Photo/Rogelio V. Solis, File)

Pfizer says 3 COVID shots protect children under 5

By Lauran Neergaard - Associated Press

FILE - In this photo provided by Pfizer, a technician handles one of the company's COVID-19 Paxlovid pills. COVID-19 patients have two new treatment options that can be taken at home. But that convenience comes with a catch: The pills have to be taken as soon as possible once symptoms appear. U.S. regulators authorized the pills from Pfizer and Merck late 2021. (Pfizer via AP, File)

Pfizer profit soars in first quarter, revises 2022 forecast

By Tom Murphy - Associated Press

Vials for the Moderna and Pfizer COVID-19 vaccines are seen at a temporary clinic in Exeter, N.H. on Thursday, Feb. 25, 2021. The Food and Drug Administration has authorized another booster dose of the Pfizer or Moderna COVID-19 vaccine for people age 50 and up, Tuesday, March 29, 2022. (AP Photo/Charles Krupa, File)

FDA authorizes a second COVID-19 booster for adults over 50

By Tom Howell Jr. - The Washington Times

A syringe is prepared with the Pfizer COVID-19 vaccine at a vaccination clinic at the Keystone First Wellness Center in Chester, Pa., on Dec. 15, 2021. Pfizer is expected to request authorization for an additional COVID-19 booster dose for seniors. (AP Photo/Matt Rourke, File) **FILE**

American taxpayers are being bilked for billions of COVID-19 dollars

By Cheryl K. Chumley - The Washington Times

In this March 4, 2021 file photo, a vial of the Moderna COVID-19 vaccine rests on a table at a drive-up mass vaccination site in Puyallup, Wash., south of Seattle. Moderna’s COVID-19 vaccine brought in nearly $7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase agreements for another $19 billion in sales this year. (AP Photo/Ted S. Warren, File)

Moderna seeks FDA authorization for 4th dose of COVID shot for all adults

By Zeke Miller - Associated Press

Kidney transplant patient Sophia Silvaamaya, 5, held by her father Pedro Silvaamaya, is vaccinated by nurse Kelly Vanderwende, Wednesday, Nov. 3, 2021, at Children's National Hospital in Washington. (AP Photo/Carolyn Kaster) ** FILE **

Scientists scramble on COVID-19 vaccine dosing; challenge remains for drugmakers

By Tom Howell Jr. - The Washington Times

Nurse Lydia Holly prepares a child's COVID-19 vaccine dose, on Nov. 3, 2021, at Children's National Hospital in Washington. U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children ages 5 and under while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February. (AP Photo/Carolyn Kaster, File)

Pfizer set to request emergency approval of COVID-19 vaccine for children younger than 5

By Tom Howell Jr. - The Washington Times

A screen shows Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), during a remote panel titled "COVID 19: What's Next?" at the Davos Agenda 2022, in Cologny near Geneva, Switzerland, Monday, Jan. 17, 2022. (Salvatore Di Nolfi/Keystone via AP) ** FILE **

Dr. Fauci pitches next vaccine — or does he?

By Cheryl K. Chumley - The Washington Times

Pharmacist Sima Manifar prepares a children's dose of the Pfizer COVID-19 vaccine during a vaccination clinic at City of Lawrence's "The Center," which serves seniors, families and the community, Wednesday, Dec. 29, 2021, in Lawrence, Mass. Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant. Pfizer and its partner BioNTech announced the study on Tuesday, Jan. 25, 2022. (AP Photo/Charles Krupa)

Pfizer opens study of COVID-19 shots updated to match omicron

Associated Press

Pharmacist Sima Manifar prepares a children's dose of the Pfizer COVID-19 vaccine during a vaccination clinic at City of Lawrence's "The Center," which serves seniors, families and the community, Wednesday, Dec. 29, 2021, in Lawrence, Mass. Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant. Pfizer and its partner BioNTech announced the study on Tuesday, Jan. 25, 2022. (AP Photo/Charles Krupa)

Pfizer launches clinical trial of omicron-specific vaccine

By Tom Howell Jr. - The Washington Times

A doctor loads a dose of Pfizer COVID-19 vaccine into a syringe, Thursday, Dec. 2, 2021, at a mobile vaccination clinic in Worcester, Mass. In January 2022, an influential government advisory panel is considering COVID-19 boosters for younger teens, as the U.S. battles the omicron surge and schools struggle with how to restart classes amid the spike. (AP Photo/Steven Senne, File)

U.S. urges COVID boosters starting at age 12 to fight omicron

By Lauran Neergaard and Mike Stobbe - Associated Press

Lucas Kittikamron-Mora, 13, holds a sign in support of COVID-19 vaccinations as he receives his first Pfizer vaccination at the Cook County Public Health Department, May 13, 2021 in Des Plaines, Ill. The U.S. is expanding COVID-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12. Boosters already are recommended for everyone 16 and older, and federal regulators on Monday, Jan. 3, 2022 decided they’re also warranted for 12- to 15-year-olds once enough time has passed since their last dose. (AP Photo/Shafkat Anowar) **FILE**

FDA clears Pfizer COVID booster for ages 12 to 15, shortens wait time for others amid omicron

By Tom Howell Jr. - The Washington Times

A medical staff member prepares the Pfizer-BioNTech COVID-19 vaccine at Tudor Ranch in Mecca, Calif. on Jan. 21, 2021. In the early days of 2021, television screens were filled with images of people across the country getting shots of the new COVID-19 vaccine. (AP Photo/Jae C. Hong, File)

FDA expands Pfizer COVID booster, opens extra dose to age 16

By Lauran Neergaard and Matthew Perrone - Associated Press

FILE - A woman lights candles forming a giant cross in memory of coronavirus victims in Germany in Zella-Mehlis, Germany, April 17, 2020. Germany is set to mark 100,000 deaths from COVID-19 this week, passing a somber milestone that several of its neighbors crossed months ago but which some in Western Europe's most populous nation had hoped to avoid. (AP Photo/Jens Meyer, File)

Germany faces grim COVID milestone with leadership in flux

By Daniel Niemann and Frank Jordans - Associated Press

A syringe is loaded with the Pfizer COVID-19 vaccine at a clinic in Richmond, British Columbia, Canada on April 10, 2021. Canada's health regulator has approved Pfizer's kid-size COVID-19 shot, Friday, Nov. 19. (Jonathan Hayward/The Canadian Press via AP, File) **FILE**

Canada approves COVID-19 vaccine for kids ages 5 to 11

By Shen Wu Tan - The Washington Times

Wren Nagata, 7, with his sister 5-year-old Mallory Nagata, of Pasadena, show off their bandaids after receiving their COVID-19 vaccines during an event kicking off coronavirus vaccinations for children age 5-11 at Eugene A. Obregon Park in Los Angeles on Wednesday, Nov. 3, 2021. (Keith Birmingham/The Orange County Register via AP)

Science says coronavirus vaccines, over time, barely effective

By Cheryl K. Chumley - The Washington Times

President Joe Biden arrives to speak about the newly approved COVID-19 vaccine for children ages 5-11 from the South Court Auditorium on the White House complex in Washington, Wednesday, Nov. 3, 2021. U.S. health officials on Tuesday gave the final sign-off to Pfizer's kid-size COVID-19 shot, a milestone that opens a major expansion of the nation's vaccination campaign to children as young as 5. (AP Photo/Susan Walsh)

Biden touts child COVID-19 vaccines after dismal election night

By Tom Howell Jr. - The Washington Times

Romeo Posada, 8, of Mercedes, Texas grimaces as he gets ready to receive the Pfizer-BioNTech COVID-19 vaccine for children five to 12 years at Edinburg Conference Center at Renaissance on Wednesday Nov., 3, 2021 in Edinburg, Texas. (Delcia Lopez/The Monitor via AP)

Maryland officials expect a third of 5-11 year olds will get vaccine in first few weeks

By Shen Wu Tan - The Washington Times

FILE - In this Dec. 29, 2020, file photo a Chester County, Pa., Health Department worker fills a syringe with Moderna COVID-19 vaccine before administering it at the Chester County Government Services Center in West Chester, Pa. Moderna said Monday, Oct. 25, 2021 that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds. It is the second U.S. vaccine aimed at eventually being offered to children. (AP Photo/Matt Slocum, File)

FDA delays decision on Moderna vaccine for adolescents

Associated Press

This October 2021, photo provided by Pfizer shows kid-size doses of its COVID-19 vaccine in Puurs, Belgium. The U.S. moved a step closer to expanding vaccinations for millions more children as a panel of government advisers on Tuesday, Oct. 26, endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. (Pfizer via AP, File)

FDA authorizes Pfizer vaccine for ages 5-11

By Tom Howell Jr. - The Washington Times